1 min read
CurQD® Selected for U.S. DoD-Funded Trial
Mar 24, 2026 - Evinature
We are thrilled to share that CurQD® has been selected for a groundbreaking clinical trial funded by the Health section of the U.S. Department of Defense (DoD). Led by Mount Sinai Hospital in New York, the study examines an integrative therapeutic approach for individuals with chronic intestinal conditions. “This approach may not only yield superior results for individuals, […]
Read more
1min read
Madrid Summit: Prof. Shomron on Epithelial Barrier Management
Jan 14, 2026- Evinature
Read more1min read
Madrid Summit: Prof. Shomron on Epithelial Barrier Management
Jan 14, 2026- Evinature
Read more